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Alzheimer’s disease (AD) is the most prevalent form of late-life dementia in the
population, characterized by amyloid plaque formation and increased tau deposition,
which is modulated by Rho-associated coiled-coil kinase 1 (ROCK1). In this study,
we further analyze whether ROCK1 regulates the metabolism of amyloid precursor
protein (APP). We show that ROCK1 is colocalized with mature amyloid-β (Aβ) plaques
in patients with AD, in that ROCK1 enhances the amyloidogenic pathway, and that
ROCK1 mediated autophagy enhances the intracellular buildup of Aβ in a cell model
of AD (confirmed by increased ROCK1 and decreased Beclin 1 protein levels, with
neuronal autophagosome accumulation in prefrontal cortex of AD APP/PS1 mouse
model). In vitro over-expression of ROCK1 leads to a decrease in Aβ secretion and
an increase in the expression of autophagy-related molecules. ROCK1 interacts with
Beclin1, an autophagy initiator, and enhances the intracellular accumulation of Aβ.
Reciprocally, overexpression of APP/Aβ promotes ROCK1 expression. Our data suggest
ROCK1 participates in regulating Aβ secretion, APP shedding and autophagosome
accumulation, and that ROCK1, rather than other kinases, is more likely to be a
targetable enzyme for AD therapy.
Keywords: Alzheimer’s disease, ROCK1, autophagy, Aβ, Beclin1
INTRODUCTION
Alzheimer’s disease (AD) is the leading cause of dementia, characterized by the accumulation
of extracellular and vascular amyloid in the brain. Amyloid plaques are composed of amyloid-β
(Aβ) peptides, and they are derived from the sequential cleavage of the amyloid precursor
protein (APP) by a set of proteases. The cleavage of APP occurs through two different pathways:
Abbreviations: AD, Alzheimer’s disease; APP, amyloid precursor protein; Aβ, amyloid-β; CoIP,
co-immunoprecipitation; PtdIns3KC3, phosphatidylinositol 3-kinase class III; ROCK1, Rho-associated coiled-
coil kinase 1; 3-MA, 3-methyladenine.
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a non-amyloidogenic pathway mediated by α-secretase and an
amyloidogenic pathway mediated by β-secretase (Tang, 2005).
α-Secretase is a metalloprotease and disintegrin enzyme that
cleaves within the Aβ sequence to generate a secreted APP
fragment (sAPPα). sAPPα has neurotrophic properties and
promotes neurite outgrowth modulating the efficacy of synaptic
neurotransmission (Ma et al., 2009). Conversely, APP cleavage
by β-secretase occurs at the N-terminus with the C-terminal
APP fragment subsequently cleaved by γ-secretase leading to the
production of Aβ peptides.
Rho-associated coiled-coil kinases (ROCKs) are Ser/Thr
kinases and the first identified effectors of Rho GTPase. They
are involved in several aspects of cell behavior, such as cell
motility, cell proliferation and apoptosis (Chang et al., 2006;
Yang et al., 2013; Loirand, 2015; Swanger et al., 2015). Research
indicates that ROCKs are potential therapeutic targets for Aβ
metabolism modulation (Weggen et al., 2001; Jacobs et al.,
2006; Salminen et al., 2008). Two constitutively-expressed
ROCK enzymes have been identified—ROCK1 and ROCK2 that
share 92% homology in their kinase domain and differ
most in their regulatory domains and subcellular localization
(Ishizaki et al., 1997; Shi et al., 2013; Chong et al., 2016).
Recent studies show that ROCK1 modulates the shedding
of the α-secretase-cleaved soluble APP ectodomain (sAPPα)
from cultured cells, and that ROCK1 depletion reduces the
levels of Aβ (Herskowitz et al., 2013; Henderson et al.,
2016). The buildup of internal Aβ rather than its external
deposition is associated with neuronal loss in APP/PS1 knock-in
mice suggesting externalization of cellular Aβ is protective
(Christensen et al., 2008). However, the mechanism by which
ROCK1 externalizes Aβ or regulates Aβ production remains to
be determined.
In AD, autophagy directly affects the secretion of Aβ
and amyloid plaque formation (Nilsson et al., 2013), and
long-term rapamycin treatment reduces Aβ plaque load by
the induction of autophagy in an AD mouse model (Nilsson
et al., 2013). The pivotal role for autophagy in the clearance of
aggregate-prone proteins also manifests with an accumulation
of autophagic vacuoles (autophagosomes and autolysosomes)
in several neurodegenerative diseases (Zhang et al., 2016).
Beclin1-mediated autophagy is the major cellular pathway
for degradation of aggregated proteins and is required for
the formation of double-membrane vesicles, cytoplasmic
organelles called an autophagosome (McLeland et al., 2011).
This dynamic process involves autophagosome formation,
autophagosome-lysosome fusion and the degradation of
autophagosomal contents by all kinds of hydrolases (Hong
et al., 2016). During the process of autophagosome biogensis,
Beclin1 plays a central role and governs the autophagic
process by binding to phosphatidylinositol 3-kinase class
III (PtdIns3KC3), which recruits additional autophagic
proteins for autophagosome formation (Miki et al., 2016).
ROCK1 phosphorylation of Beclin1 is the critical regulator
for stress-induced autophagy (Gurkar et al., 2013). A
reduction in ROCK1 is thought to diminish Aβ levels by
enhancing lysosomal degradation of APP (Henderson et al.,
2016).
To investigate the involvement of ROCK1 in the Aβ
pathology diagnostic features for AD, the levels of and location
of ROCK1 in brain tissue from preclinical and clinical AD
patients were examined. Aβ production and autophagosome
formation following increases or decreases in ROCK1 levels were
tested using cell culture methods. We showed that ROCK1 is
deposited with highly aggregated Aβ in human brain tissue,
and that activated ROCK1 inhibits autophagic Aβ clearance
via interaction with Beclin1, increasing Aβ burden during AD
progression.
MATERIALS AND METHODS
Pathological Cohort
The human ethics committee of the University of New
South Wales approved this tissue study. Following institutional
approvals, 10 µm formalin-fixed paraffin-embedded temporal
cortex sections from 17 cases with different severities of
AD pathology (female: male = 13:4, age = 87 ± 9.5 (years
old), post mortem delay = 15 ± 11 (h), low severity,
Braak stages 0–2 and not demented: intermediate severity
and Braak stages 3–4: high severity, Braak stages 5–6 and
dementia = 5:3:9) were obtained from the Sydney Brain
Bank which collects brain tissue with informed consent from
longitudinally followed research participants. Subjects were
characterized according to recent criteria for the pathological
diagnosis of AD. One of the cases with an intermediate severity
had a diagnosis of AD for 3 years, while all those with
a high probability of AD had dementia for between 5 and
17 years. Exclusion criteria were alternate neurodegenerative
disorders or a dominant family history of neurodegenerative
disorder.
Immunofluorescence
For immunofluorescence, the 10 µm formalin-fixed,
paraffin-embedded sections underwent heat-induced antigen
retrieval with Citrate Buffer pH 6 for 3 min, followed by
formic acid pre-treatment for 3 min. Tissue sections were
double-labeled with rabbit anti-ROCK1 (1:50, Abcam) and
mouse monoclonal anti-human Aβ1–42 (1:200, M0872, Dako,
Glostrup, Denmark), and visualized with goat anti-rabbit
Alexa Fluor 488 (1:500, A-11008, Life Technologies) and
goat anti-mouse Alexa Fluorr 594 (1:500, A-11005, Life
Technologies), respectively. Sections were coverslipped
with Vectashield HardSet Antifade Mounting Medium
with DAPI (H-1500, Vector Laboratories, Burlingame, CA,
USA) and examined on confocal microscope (Nikon Eclipse
E400).
Quantitative Analysis of Aβ and
ROCK1 Colocalization
For quantification, 10 images were made for each case where
plaques were present. All diffuse and cored plaques on each
image was identified using the Aβ1–42 immunofluorescence,
and the proportion that had ROCK1 co-localization recorded
separately for both diffuse and core plaques. In total, an
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average of 40 ± 17 plaques were examined per case, with 66%
on average being diffuse and 36% being cored. Multivariate
statistics were performed in SPSS (IBM, v23) to assess
differences between the percentages of plaques colocalizing
ROCK1 immunoreactivity and the severity of cortical plaques
observed, as assessed by the CERAD score (0 = none,
1 = mild or 1–5/image, 2 = moderate or 6–15/image and
3 = severe or more than 15/image), as well as to case
diagnosis based on pathological load of different plaque
types and neurofibrillary tangles (control, preclinical AD and
AD).
Cell Lines and Cell Culture
HEK293 cells stably transfected with human APP695 harboring
the ‘‘Swedish’’ mutation (HEK293 APP695sw) and SH-SY5Y
human neuroblastoma were maintained in Eagle’s minimal
essential media or DMEM (Gibco), respectively, with 10%
fetal bovine serum, and 1% penicillin/streptomycin. Cells were
plated at 100,000 cells/cm2 density in 6-well dishes that were
coated with 100 µg/ml poly-lysine. On day 2 post plating, cells
were transduced with indicated lentivirus with a multiplicity
of infection of 1. For all studies, cells were treated with
drugs at 72 h post-transduction in conditioned media for
16 h. For RNAi knockdown of ROCK1, cells were harvested
96 h post-transduction. For transductions or transfections,
equivalent amounts of cells were plated, and transfections were
performed using Lipofectamine 2000 (Invitrogen) according to
the manufacturer’s instructions. At 72 h post-transfection, cells
were treated as indicated and then processed for western blot
analysis or fluorescence imaging.
Cell Proliferation Assay
Cell proliferation was measured by the CCK-8 Kit (Beyotime)
according to the manufacturer’s instructions. Cells in 100 µl
media were treated with 10 µl CCK-8 reagent at 37◦C for 2 h,
followed by measuring the absorbance at 450 nm on a microplate
reader.
Plasmid Construct, RNA Interface and
Transfection
ROCK1 plasmid (pCAG-myc-ROCK1myc-727 ∆3, ROCK1 CA)
was constructed as previously reported (Ishizaki et al.,
1997). The siRNA sequence against ROCK1 (sense
5′-GGCAGAGGAAGAAUAUAAATT-3′; antisense
5′-UUUAUAUUCUUCCUCUGCCTT-3′) and scrambled
siRNA was synthesized by GenePharma (Shanghai, China).
Cells were transfected with ROCK1 plasmid, ROCK1 siRNA or
scrambled siRNA using Lipofectamine 2000 reagent according
to the manufacturer’s instructions. At 72 h post-transfection,
cells and supernatant were harvested and then processed for
western blot analysis.
Aβ Measurements
For all cells, conditioned media were used for 48 h, and
then the cells and media collected separately for biochemical
analyses. Aβ40 was detected using a sandwich ELISA for human
Aβ40 following the manufacturer’s instructions. Plates were read
at 450 nm on a Synergy MX plate reader (BioTeck, Winooski,
VT, USA).
Immunoblotting
Cells were lysed with 1% RIPA Lysis Buffer (Beyotime, China).
Cell lysate was subjected to a 13,000 rpm spin to remove
nuclei and debris. Cleared lysate was used for the indicated
biochemical assay. Protein concentrations were determined
using the Enhanced BCA Protein Assay Reagent (Beyotime).
Equal amounts of cell lysate were loaded onto SDS-PAGE
gels and then transferred to PVDF membranes. Membranes
were blocked with 5% fat-free dry milk in Tris buffered
saline (TBS), containing 0.05% Tween-20, and incubated with
primary antibodies. Protein bands were detected by horseradish
peroxidase-conjugated species-specific secondary antibodies.
Actin was used as loading control. Images were captured using
an Odyssey Image Station (LI-COR), and band intensities were
quantified using Scion Image.
mCherry-GFP-LC3B Assay
In order to evaluate the effects of ROCK1 plasmid on GFP–LC3B
puncta formation, SH-SY5Y cells were plated on poly-lysine-
coated 96-well plates and transduced with adenovirus expressing
mCherry-GFP-LC3B fusion protein. After 24 h and 48 h, cell
images were obtained by EVOS fl Auto (Life, USA).
Co-Immunoprecipitation
Co-immunoprecipitation (CoIP) was performed as previously
described (Rijal Upadhaya et al., 2014). HEK293 cells in 60-mm
dishes were co-transfected with pCAG-myc-ROCK1myc-727
∆3 plasmid. Forty eight hours later, the cells were lysed
with 1% RIPA Lysis Buffer (Beyotime). After clarification by
centrifugation at 4◦C for 30 min at 12,000 rpm, 500 µl cell
lysates were incubated with 20 µl of protein A + G agarose
beads (Beyotime, China) for 4 h with gentle rotation at 4◦C.
The beads were washed four times with the cell lysis buffer and
precipitates were eluted with 2× SDS-PAGE sample buffer, and
then analyzed by western blot for anti-Myc and anti-Beclin1
immunoreactivity, respectively.
Primary Neuron Culture, Transfection and
Immunofluorescence
Primary cortical neurons were prepared from E16 to E18 days
of Sprague-Dawley rat brain tissues. Briefly, cerebral cortex was
removed aseptically, and then digested and dispersed into single
cells; then neurons were re-suspended in neuro-basal medium
with 2% B27 supplement (Invitrogen), 2mM glutamine and 1%
penicillin and streptomycin (Invitrogen, Carlsbad, CA, USA)
and then seeded at 1.25 × 105 cells per cm2 on 12-well plates
(Corning Inc., Midland, NC, USA) coated with 100µg/ml poly-
l-lysine and incubated in humidified atmosphere with 5% CO2 at
37 ◦C. Transfection using Lipofectamine 2000 (Invitrogen) was
carried out on acutely dissociated neurons before plating, and
4 h later, the whole medium was replaced with NB/B27 and
immunofluorescence experiment was performed after 48 h
transfection.
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For immunofluorescence, primary neurons were cultured
on a cover glass and fixed with 4% paraformaldehyde in
PBS for 10 min at room temperature. Permeabilization
was performed in PBS with 0.3% Triton X-100 for 10 min
at room temperature. After blocking for 30 min with 5%
normal donkey serum, neurons were incubated with rabbit
anti-LC3 (1:100, CST) antibody or mouse anti-ROCK1 (1:500,
Abcam) antibody overnight at 4◦C. After washing three
times with 0.1 M PBS, the sections were incubated with
AlexaFluor 488-conjugated donkey anti-rabbit or anti-mouse
IgG secondary antibodies (Invitrogen), respectively, and
the sections were visualized with a confocal microscope
(FV-1000).
Immunohistochemistry and Histology
APP/PS1 mice were provided by Model Animal Research
Center of Nanjing University. APP/PS1 mice have been
intensively characterized for Aβ plaques load and AD
behavioral phenotypes. In this experiment, 10-month-old
APP/PS1 transgenic mice and age-matched C57BL/6J were used.
Mice were deeply anesthetized and perfused with 10% formalin,
and their brains were removed and fixed in 4% paraformaldehyde
in PBS overnight at 4◦C.Whole brains were cryoprotected in 25%
sucrose in 0.1M PBS at 4◦C until sectioning. The brain tissues
were cut in to coronal 30 µm sections. Immunohistochemistry
(IHC) for APP and Beclin1 were performed using primary
antibodies of 6E10 (1:100, Novus) and rabbit anti-Beclin1
(1:100, Novus) respectively (Sugrue et al., 2010). APP and
Beclin1 immunopositive neurons were quantified according to
the previously established method (Dlugos and Pentney, 2002).
Antibodies and Reagents
Mouse anti-ROCK1 antibody (Abcam, 1:500 dilution), rabbit
anti-Beclin1 (Novus, 1:10,000), rabbit anti-APP-CTF (Sigma-
Aldrich, 1:5000), anti-mouse sAPPα (IBL, 1:50), anti-mouse
myc (Abcam, 1:1000), anti-rabbit LC3 (Cell Signaling, 1:100)
and mouse anti-β-actin (Sigma-Aldrich, 1:1000) were used.
Loading controls (β-actin) were used for Western blot
standardization. Lipofectamine 2000 was sourced from
Invitrogen. 3-methyladenine (3-MA) was purchased from
Sigma Aldrich (St. Louis, MO, USA) and 3-MA was dissolved in
double distilled water and titrated to 1 mM.
Statistical Analysis of the Cell Culture Experiments
Data are reported as mean ± SEM. Comparisons between
experimental groups were analyzed by Student’s t-test or
ANOVA as appropriate, with p< 0.05 considered as significant.
RESULTS
ROCK1 is Associated with Aβ Plaques in
the Brains of AD Patients
To determine whether Aβ associates with ROCK1 in the brains
of patients with AD, co-localization studies were performed
using specific antibodies in healthy aged controls (n = 5 aged
89 ± 4 years, Braak neuritic stages 0–2), preclinical AD
(n = 4 aged 85 ± 3 years, Braak neuritic stages 3–4) and clinical
end-stage AD (n = 8 aged 86 ± 4 years, Braak neuritic stages
5–6). Consistent with this finding, ROCK1 immunoreactivity
was identified in more cored than diffuse plaques (Figure 1).
Quantitation showed that the majority of cored plaques
contained ROCK1 immunoreactivity, and that colocalization
increased with increasing severity of cortical Aβ deposition as
assessed by CERAD plaque score (Figure 1J, Wilks’ Lambda
p < 0.0001 covarying for age and brain size, post hoc Bonferroni
p = < 0.002). Nearly half of all Aβ plaques in preclinical
AD contained ROCK1 immunoreactivity, with significantly
higher numbers of ROCK1-immunopositive Aβ plaques found
in AD patients (Figure 1K, Wilks’ Lambda p = 0.03 covarying
for age and brain size, post hoc Bonferroni p = 0.003 for
AD diagnosis). These results demonstrate a close relationship
between ROCK1 localization and pathological Aβ plaque in both
preclinical and clinical AD.
ROCK1 Regulates Aβ Secretion
To further explore the effects of ROCK1 cleavage on the
production of Aβ, we constructed a plasmid expressing
this constitutively active ROCK1 fragment (ROCK1 CA), as
previously reported (Ishizaki et al., 1997). In HEK 293T cells
stably transfected with the APP695 Swedish mutation (APPsw),
ROCK1 levels weremanipulated by transfection with ROCK1CA
plasmid, ROCK1 siRNA or scrambled siRNA. Forty eight hours
after transfections, the levels of secreted Aβ40 in the cell culture
medium were measured by ELISA. As shown in Figure 2,
secreted Aβ40 levels were increased by 80% compared to the
control after depletion of ROCK1 (Figures 2A,B), which is
consistent with a recent study. In contrast, secreted Aβ40 levels
were decreased following ROCK1 CA over-expression in
HEK293T APPsw cells (Figures 2C,D). The Aβ42 level was too
low to be detected by ELISA. ROCK1 CA plasmid transfection
did not change cell proliferation (Figure 2E). These results
confirm that ROCK1 influences Aβ secretion.
ROCK1 Modulates APP Shedding
Given that there is an established relationship between
ROCK1 and Aβ secretion, we next investigated the effects of
ROCK1 on APP cleavage. After transfection of ROCK1-targeted
siRNA or ROCK1 CA plasmid to HEK293T APPsw cells, cells
were harvested 48 h later and lysates were analyzed. The
holo-APP and sAPPα were examined by Western Blot with
the mAb 6E10, specific for residues 1–17 of the Aβ sequence
(Figure 3A). Electrophoresis revealed no significant difference
of full-length APP (Figure 3C), however the amount of sAPPα
was higher after ROCK1 depletion (Figure 3D). In cells with
increased ROCK1 CA levels, sAPPα was significantly decreased
(Figure 3D). These results confirm that ROCK1 modulates the
metabolism of APP. To further explore the interaction between
ROCK1 and APP/Aβ, we performed normal HEK293T cell
culture with Aβ40 treatment or APP695 plasmid transfection.
Addition of Aβ40 or APP695 over-expression promoted
endogenous ROCK1 expression in normal HEK293T cells
(Figures 3B,E).
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FIGURE 1 | Co-localization of Rho-associated coiled-coil kinase 1 (ROCK1) and amyloid-β (Aβ) in cortical plaques. Confocal microscopy using specific
antibodies to Aβ (red) and ROCK1 (green) revealed a high degree of co-localization in the dense cores of cortical Aβ plaques and less overlap with diffuse Aβ
depositions in the cortex (A–I). Quantitation of the degree of colocalization in Aβ plaques was assessed in 40 ± 17 temporal lobe plaques in each case with Aβ
plaque deposition (n = 14/17). Multivariate analysis identified a significant increase (∗p < 0.02) in ROCK1 and Aβ colocalization in plaques with increasing cortical
deposition of Aβ plaques, as assessed by the CERAD plaque score (J). With increasing CERAD plaque severity, more cored plaques contained ROCK1
immunoreactivity, whereas colocalization of ROCK1 and Aβ in diffuse plaques was mainly observed when there was a high cortical load of Aβ (J). Multivariate
analysis revealed that the degree of colocalization of ROCK1 and Aβ in cored plaques was highest in patients with clinical Alzheimer’s disease (AD; ∗p = 0.003),
although significant numbers of Aβ plaques contained ROCK1 immunoreactivity in preclinical AD (K).
Identification of ROCK1 as an Enhancer of
Beclin1 Dependent Autophagy
In further experiments, we explored the mechanism of
ROCK1 as an enhancer of Beclin 1 dependent autophagy.
When ROCK1 was depleted, the expression of Beclin1 was
decreased, and when ROCK1 CA was over-expressed by
plasmid transfection, the level of Beclin1 was also increased.
To determine whether autophagy is involved in the mechanism
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FIGURE 2 | ROCK1 levels modulate Aβ secretion. (A,C) Effects of knocking down ROCK1 levels (A) and increasing constitutively activated ROCK1 (ROCK1 CA)
levels (C) on secreted Aβ. HEK293 cells were transfected with ROCK1 siRNA (siROCK1), scramble siRNA (siCON), ROCK1 CA plasmid and pcDNA (Con) and 48 h
post-transfection secreted Aβ40 was measured by ELISA. (B,D) Representative immunoblot confirms ROCK1 knockdown (B) and increase (D). (E) Cell proliferation
assay following ROCK1 CA plasmid transfection. Data are presented as Mean ± SEM. Graphs represent % of control groups, n = 10; students’ t test, ∗∗∗p < 0.01.
by which ROCK1 depletion increases Aβ secretion, SH-SY5Y
cells were co-transfected with mCherry-LC3B adenovirus and
ROCK1 CA plasmid and the patterns of LC3 puncta were
analyzed by immunoflouresence. Figure 4A shows an increase
in LC3 puncta after ROCK1 CA plasmid transfection. LC3 was
also assessed in HEK293T cells and, as the results show,
the LC3II/I ratio was increased in cells when ROCK1 CA
was over-expressed and decreased following ROCK1 depletion
(Figures 4E,G). We also explored whether ROCK1 interacted
with Beclin1 during autophagy (Figures 4B,C). HEK293T
cells transfected with myc-tagged human ROCK1 were lysed
and the proteins subjected to co-immunoprecipitation with
anti-ROCK1 and anti-myc antibody. Our results showed that
endogenous ROCK1 and Beclin1 interacted with each other.
Moreover, when ROCK1 CAwas over-expressed, this interaction
was enhanced (Figures 4D,F). These results showed that
an interaction between ROCK1 and Beclin1 triggered the
autophagic build-up of intracellular Aβ and a decrease in Aβ
secretion.
To further elucidate ROCK1 influence on autophagy, 3-MA
was used as an inhibitor of autophagy. After HEK293T APPsw
cells were treated with 3-MA for 6 h, they were transfected
with ROCK1 CA plasmid for 48 h. To test whether ROCK1 CA
over-expression rescued 3-MA-induced autophagy inhibition,
the cells were lysed and proteins analyzed by ELISA andWestern
blot. Inhibiting autophagy increased intracellular Aβ40 levels
(Figure 4J), and over-expression of ROCK1 by transfection with
ROCK1 CA plasmid reversed this effect even though 3-MA
treatment decreased Beclin1 levels (Figures 4H,I).
APP/PS1 Mice have Increased ROCK1 and
Neuronal Autophagosome Accumulation
After confirming the relationship between ROCK1 and
autophagosome formation in vitro, we next assessed whether
ROCK1 and autophagosome proteins are upregulated
with Aβ in vivo by conducting immunofluorescence
and IHC staining of brain sections from 10 months old
APP/PS1 transgenic C57BL/6 mice. Our data showed
that ROCK1 was increased significantly with neuronal
autophagosomes accumulation (Figures 5A,C) and
that Beclin1 was decreased in the AD mouse model
(Figures 5B,D). These observations suggested that autophagy
was impaired in neurons and increased ROCK1 inhibited
Aβ secretion, resulting in intracellular Aβ accumulation and
neurotoxicity. Taken together, these data demonstrated the
same associations between ROCK1, intracellular Aβ and
autophagosomes accumulation as we identified in our in vitro
experiments.
DISCUSSION
The critical events that trigger or cause increased Aβ levels
and post-translational modifications that increase Aβ
insolubility are still under debate. However, modulation
of the production, metabolism and fibrilization of the
protein are key pathogenic aspects. Our results show that
ROCK1 levels regulate Aβ clearance by modulating the
autophagy pathway via an interaction with its substrate, Beclin1,
that initiates autophagosome formation that then accumulate
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FIGURE 3 | ROCK1 modulates amyloid precursor protein (APP) shedding. (A) Immunoblot analysis of sAPPα and APP full-length (APP FL) following
ROCK1 knockdown and ROCK1 increase. (B) Immunoblot of ROCK1 after Aβ40 treatment and APP695 plasmid transfection in HEK 293T cells. (C–E)
Quantification of APP FL (C), sAPPα (D) and ROCK1. Data are presented as Mean ± SEM, n = 12, students’ t test, ∗∗∗p < 0.001, ∗∗p < 0.01.
intracellularly. This is consistent with previous studies showing
that ROCK1 regulates autophagosome formation (Gurkar
et al., 2013), that autophagosomes accumulate in AD and
that ROCK1 inhibition reduces Aβ levels in brain (Nixon
and Yang, 2011). Our data also show that ROCK1 collocates
with fibrilized Aβ. It has recently been shown that different
post-translational modifications of Aβ occur in different types
of plaques (Rijal Upadhaya et al., 2014). The cases in this
study have been previously analyzed using Western blotting for
ROCK1 with no reduction in membrane associated SDS-soluble
ROCK1 protein levels by end-stage AD (Wang et al., 2016).
Taken together, our data indicate that ROCK1 may be involved
in Aβmodification.
Phosphorylation of Aβ at serine 8 at the cell surface
has recently been identified to dramatically increase the
rate and amount of Aβ oligomerization and amyloid
fibril formation (Rezaei-Ghaleh et al., 2016). In fact, AD
patients are distinguished from those without clinical AD
by selectively accumulating this phosphorylated form of Aβ
(Rijal Upadhaya et al., 2014). The kinases that are involved in
phosphorylating Aβ are poorly understood, but are thought
to be of the AGC kinase family of serine-threonine kinases
(Rezaei-Ghaleh et al., 2016), which includes ROCK1. Unlike
ROCK2, ROCK1 interacts with a number of proteins in
the plasma membrane (Stroeken et al., 2006) and we show
that ROCK1 co-localizes with highly fibrilized Aβ in human
brain. The localization and association of ROCK1-associated
Aβ with clinical AD mirrors the data observed for serine
8 phosporylated Aβ (Rijal Upadhaya et al., 2014) and suggests
that ROCK1 may be the kinase involved in this disease-specific
Aβ phosphorylation.
We provide further evidence that ROCK1 has a role in
the plasma membrane in its influence on APP shedding.
APP shedding is directly mediated by α- and β-secretase
generating either non-amyloidogenic (sAPPα) or amyloidogenic
fragments (Tang, 2005). Our data show that ROCK1 activation
enhances the amyloidogenic pathway, consistent with recent
data (Henderson et al., 2016). However, we demonstrate that
ROCK1 decreased sAPPα shedding in cultured cells, but also
reduced rather than increased Aβ secretion from the cells,
suggesting that ROCK1 may also play a role in Aβ secretion at
the plasma membrane (potentially associated with the aberrant
phosphorylation of Aβ, see above). Together these results are
also consistent with ROCK1 activation increasing intracellular
Aβ.
We show that activated ROCK1 inhibits the autophagic
clearance of Aβ via its interaction with Beclin1, increasing
Aβ burden during AD progression. Autophagy is a critical
clearance system for cellular toxic protein aggregates and
it is crucial for the physiological regulation of normal cell
function, which can be induced by extracellular and intracellular
signals, including oxidative stress, starvation and endoplasmic
reticulum stress (Wang and Mao, 2014). In the brain, the
complex axonal and dendritic structures are highly dependent
on efficient autophagic turnover (Wong and Holzbaur, 2015;
Hong et al., 2016). In AD, autophagy is upregulated at early
disease stages, as evidenced by swollen endosomes and the
accumulation of autophagosomes (Wong and Holzbaur, 2015).
At the transcriptional level, autophagy-activating factors are also
upregulated in AD (Jiang et al., 2013). ROCK1 phosphorylation
of Beclin1 is known to be the critical regulator for stress-induced
autophagy (Gurkar et al., 2013). We confirm that Beclin1 is a
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FIGURE 4 | ROCK1 increases autophagy via an interaction with Beclin1. (A) Increased ROCK1 CA levels induced an increase in the intracellular
autophagosome formation and accumulation. SH-SY5Y cells (upper panels) and primary neurons (lower panels) were co-transfected with ROCK1 CA plasmid and
mCherry-GFP-LC3B adenovirus (pcDNA was used as a control). Fluorescence microscopy was used to detect the formation of GFP-LC3 puncta after 24 h
post-transfection. (B) Expression of Beclin1 following ROCK1 knockdown and ROCK1 CA over-expression. (C) Quantification of Beclin1 following
ROCK1 knockdown and ROCK1 CA over-expression. (D) HEK293 cells transfected with ROCK1 CA plasmid and pcDNA. Forty eight hours post-transfection
co-immunoprecipitation (CoIP) was performed with cell lysates by using ROCK1 crosslinked agarose and then blotted with antibodies. (E) Representative
immunoblot of LC3 II/LC3 I after ROCK1 CA over-expression and ROCK1 knockdown. (F) Quantification of CoIP Beclin1 levels. (G) Representative immunoblot of
LC3 II/LC3 I after ROCK1 CA over-expression and ROCK1 knockdown. (H) Representative immunoblot of LC3 II/LC3 I after ROCK1 CA over-expression and
ROCK1 knockdown. (I) ROCK1 CA plasmid transfection reverses 3-methyladenine (3-MA) induced autophagy inhibition. Representative immunoblot of LC3 II/LC3 I.
(J) Increased Aβ40 secretion after 3-MA treatment (48 h) by ELISA. Data are presented as Mean ± SEM, students’ t test, ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001.
substrate of ROCK1 and that the interaction of ROCK1 and
Beclin1 results in the inhibition of autophagic Aβ clearance.
It is well known that Beclin1 is a critical regulator of
autophagy and several lines of investigation have demonstrated
that autophagy plays an important role in Aβ clearance
(also known as ‘‘autophagic Aβ clearance’’; Wirawan et al.,
2012). Although ROCK1 phosphorylation of Beclin1 activates
autophagosome production, our data show that these organelles
accumulate intracellularly with enhanced intracellular Aβ
and a reduction in secreted Aβ. This is consistent with
previous reports showing that autophagosome maturation to
autolysosomes is the main problem with autophagy in AD
and results in accumulating intracellular Aβ (Nixon and Yang,
2011).
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FIGURE 5 | ROCK1 is up-regulated with neuronal autophagosome accumulation in AD mice. (A) Representative ROCK1 (upper panels) and LC3 (lower
panels) immunofluorescence in AD and normal mouse brain sections. (B) Representative immunohistochemical (IHC) micrographs of Aβ (6E10, upper panels) and
Beclin1 (lower panels) immunofluorescence in AD and normal mouse brain sections. (C) Quantification of ROCK1 immunopositive neurons in AD mouse brain
sections compared to control sections (n = 4). (D) Quantification of Beclin1 immunopositive neurons in AD mouse brain sections compared to control sections
(n = 4). Data are expressed as mean ± SEM; ∗∗p < 0.01, ∗∗∗p < 0.001.
Overall our data suggest a role for ROCK1 in regulating Aβ
production, secretion and post-translational modification at the
plasma membrane, as well as its important role in intracellular
autophagosome induction. The location of ROCK1 to the plasma
membrane (Stroeken et al., 2006), and also in extracellular
plaques (as shown in this study), makes this kinase potentially
more easily targetable and relevant for therapeutic manipulations
than others. If as suggested, Aβ phosphorylation at serine
8 enhances plaque maturation to progress presymptomatic
pathology to symptomatic AD (Rijal Upadhaya et al., 2014), then
inhibition of ROCK1 and/or Aβ dephosphorylating enzymes,
may provide the most relevant treatments. Taken together, our
findings outline a critical role of ROCK1 in the progression
of Aβ pathology, highlighting its potential as a therapeutic
target.
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